Scholarlink

<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multifactorial disorder with immunometabolic imprints that differ significantly by sex. Although sex differences in disease susceptibility and progression have been recognized in other systems, they remain understudied in MASLD. Here, we explore how sex-based immune responses, metabolic stressors (diet, drugs, and lifestyle), and the gut microbiome contribute to disease variability. Wherever applicable, we take into account sex as a biological variable. We also analyzed phylum-level microbiome data from Human Gut Microbiome Atlas using an interpretable machine learning framework to predict and explain the classification features associated with MASLD. Our integrative approach underscores the need for sex-specific diagnostics and interventions incorporating host–microbiome–immune interactions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Visiting MASLD through the lens of sex, immunity, and microbial interactions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月14日

查看全文
  • Snehanjali Puhan,
  • Smaroki Smruti Rekha,
  • Kartika Sahu,
  • Tanuja Mohanty,
  • Arka Jyoti De,
  • Ankita Das,
  • Palok Aich

摘要

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multifactorial disorder with immunometabolic imprints that differ significantly by sex. Although sex differences in disease susceptibility and progression have been recognized in other systems, they remain understudied in MASLD. Here, we explore how sex-based immune responses, metabolic stressors (diet, drugs, and lifestyle), and the gut microbiome contribute to disease variability. Wherever applicable, we take into account sex as a biological variable. We also analyzed phylum-level microbiome data from Human Gut Microbiome Atlas using an interpretable machine learning framework to predict and explain the classification features associated with MASLD. Our integrative approach underscores the need for sex-specific diagnostics and interventions incorporating host–microbiome–immune interactions.